Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label, Inpatient Study of Levotofisopam 50 mg TID Administered for 7 Days to Men and Postmenopausal Women With Hyperuricemia and Gout

NCT01519687 is registered in ClinicalTrials.gov with Pharmos as lead sponsor.

NCT NCT01519687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01519687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label, Inpatient Study of Levotofisopam 50 mg TID Administered for 7 Days to Men and Postmenopausal Women With Hyperuricemia and Gout
Lead sponsor
Pharmos
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2012
Completion date
June 30, 2012
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gout, hyperuricemia